Chinese Marketing Green Light Granted For Biox' Wireless Patient Monitor

Vasomedical's wholly owned subsidiary, Biox Instruments, has received approval from the China State FDA to begin marketing its MobiCare wireless patient monitor in China.

The MobiCare wireless patient monitor is a vital signs monitoring system that acquires and displays multiple physiological signals, including ECG, blood pressure, respiration, peripheral capillary oxygen saturation and body temperature, as well as provides real-time detection and alerts for certain abnormalities in these vital signs. MobiCare transmits patient signals wirelessly to a touch-screen tablet receiver or a bedside monitor. MobiCare's wireless connectivity untethers patients from the bedside monitor, allowing them movement within a certain range.

MobiCare will first be sold to hospitals in China as a new type of bedside patient monitor, in order to cultivate acceptance of the technology and set the stage for future introduction into the fast growing global home care market.

Biolox is preparing applications for CE marking and FDA clearance for the MobiCare system.

This article is tagged to:
Related sectors of this article: Medical Devices, Patient Aids, Regulatory - Medical Devices, MIW
Geography: China, United States

Enter your details to read the full article

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.